6 October 2020
SATIVA WELLNESS GROUP INC.
("Sativa Wellness" or the "Company")
Sativa Wellness Secures Significant Product Listing with the Health Store
AQSE Growth Market Website
Sativa Wellness (AQSE and CSE: SWEL), the fully integrated European seed to consumer CBD group with the pricing, products, and stability to meet the growing CBD market demand both now and in the medium term, wishes to announce that the Company has secured a cannabidiol ("CBD") product listings with the "Health Store". The Health Store is the longest established and most respected distributer in the health food industry, who supply over 800 stores in England and Ireland and a further 130 overseas retailer stores in more than 30 different countries.
The Health Store will list the full "Goodbody Wellness" premium range - CBD with Vitamin D, to target their independent health and wholefood stores.
Sativa Wellness CEO Henry Lees-Buckley commented: "We are delighted that the Health Store have listed our Goodbody Wellness range of CBD containing Vitamin D. Consumers are demanding high quality and regulation-compliant products and that's what Goodbody products deliver. Having our Goodbody Wellness products available to this large network of stores and consumers is an honour. Goodbody Botanicals and Goodbody Wellness products are a result of Sativa Wellness Group's "seed to consumer" commitment. The group cultivates the biomass, extracts the CBD, tests the materials, formulates, bottles and tests the finished products to ensure consumers get high quality CBD they can trust".
AQSE Growth Market website
The Company would like to confirm that UK based shareholders can find the Company share trading and pricing information at the AQSE Growth Market website by entering Sativa Wellness Group or the Company ticker: "SWEL" under "Search for a Company". Please click here to view the view Company's webpage on the AQSE Growth Market website.
The Directors of the Company accept responsibility for the contents of this announcement.
Further information regarding the Company can be found at www.sedar.com.
On behalf of the Board of Directors,
This information is provided by RNS, the news service of the
. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom
. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact email@example.com
or visit www.rns.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the